Loading…

Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial

IMPORTANCE: The effects of recruitment maneuvers and positive end-expiratory pressure (PEEP) titration on clinical outcomes in patients with acute respiratory distress syndrome (ARDS) remain uncertain. OBJECTIVE: To determine if lung recruitment associated with PEEP titration according to the best r...

Full description

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2017-10, Vol.318 (14), p.1335-1345
Main Authors: Cavalcanti, Alexandre Biasi, Suzumura, Érica Aranha, Laranjeira, Ligia Nasi, Paisani, Denise de Moraes, Damiani, Lucas Petri, Guimarães, Helio Penna, Romano, Edson Renato, Regenga, Marisa de Moraes, Taniguchi, Luzia Noriko Takahashi, Teixeira, Cassiano, Pinheiro de Oliveira, Roselaine, Machado, Flavia Ribeiro, Diaz-Quijano, Fredi Alexander, Filho, Meton Soares de Alencar, Maia, Israel Silva, Caser, Eliana Bernardete, Filho, Wilson de Oliveira, Borges, Marcos de Carvalho, Martins, Priscilla de Aquino, Matsui, Mirna, Ospina-Tascón, Gustavo Adolfo, Giancursi, Thiago Simões, Giraldo-Ramirez, Nelson Dario, Vieira, Silvia Regina Rios, Assef, Maria da Graça Pasquotto de Lima, Hasan, Mohd Shahnaz, Szczeklik, Wojciech, Rios, Fernando, Amato, Marcelo Britto Passos, Berwanger, Otávio, Ribeiro de Carvalho, Carlos Roberto
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IMPORTANCE: The effects of recruitment maneuvers and positive end-expiratory pressure (PEEP) titration on clinical outcomes in patients with acute respiratory distress syndrome (ARDS) remain uncertain. OBJECTIVE: To determine if lung recruitment associated with PEEP titration according to the best respiratory-system compliance decreases 28-day mortality of patients with moderate to severe ARDS compared with a conventional low-PEEP strategy. DESIGN, SETTING, AND PARTICIPANTS: Multicenter, randomized trial conducted at 120 intensive care units (ICUs) from 9 countries from November 17, 2011, through April 25, 2017, enrolling adults with moderate to severe ARDS. INTERVENTIONS: An experimental strategy with a lung recruitment maneuver and PEEP titration according to the best respiratory–system compliance (n = 501; experimental group) or a control strategy of low PEEP (n = 509). All patients received volume-assist control mode until weaning. MAIN OUTCOMES AND MEASURES: The primary outcome was all-cause mortality until 28 days. Secondary outcomes were length of ICU and hospital stay; ventilator-free days through day 28; pneumothorax requiring drainage within 7 days; barotrauma within 7 days; and ICU, in-hospital, and 6-month mortality. RESULTS: A total of 1010 patients (37.5% female; mean [SD] age, 50.9 [17.4] years) were enrolled and followed up. At 28 days, 277 of 501 patients (55.3%) in the experimental group and 251 of 509 patients (49.3%) in the control group had died (hazard ratio [HR], 1.20; 95% CI, 1.01 to 1.42; P = .041). Compared with the control group, the experimental group strategy increased 6-month mortality (65.3% vs 59.9%; HR, 1.18; 95% CI, 1.01 to 1.38; P = .04), decreased the number of mean ventilator-free days (5.3 vs 6.4; difference, −1.1; 95% CI, −2.1 to −0.1; P = .03), increased the risk of pneumothorax requiring drainage (3.2% vs 1.2%; difference, 2.0%; 95% CI, 0.0% to 4.0%; P = .03), and the risk of barotrauma (5.6% vs 1.6%; difference, 4.0%; 95% CI, 1.5% to 6.5%; P = .001). There were no significant differences in the length of ICU stay, length of hospital stay, ICU mortality, and in-hospital mortality. CONCLUSIONS AND RELEVANCE: In patients with moderate to severe ARDS, a strategy with lung recruitment and titrated PEEP compared with low PEEP increased 28-day all-cause mortality. These findings do not support the routine use of lung recruitment maneuver and PEEP titration in these patients. TRIAL REGISTRATION: clinicaltrials.gov Identifi
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2017.14171